Eliason, L
Mayo Clinic
GlaxoSmithKline, Bengaluru (India), 17*Upper Providence (USA), 17†Zug (Switzerland)
Citations 1
P13: CAN PATIENT-REPORTED OCULAR SYMPTOMS GUIDE DOSE MODIFICATIONS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING BELANTAMAB MAFODOTIN?
Popat, Rakesh , Badros, Ashraf , Kumar, Seema, Cohen, Alan R., Manier, Salomon , Voorhees, Peter M. , Rifkin, Robert M. , Martin, T., Jeng, Bennie H. , Lee, H, Berdeja, J. G., Jadhav, Vinay, Tosolini, A, Eliason, L, Palumbo, A, Trudel, S., Richardson, PG, Popat, Rakesh , Rodríguez‐Otero, Paula , Gay, Francesca , Chari, Ajai , Weisel, Katja C , Farooq, Asim V. , Chng, Wee Joo , Palumbo, Antonio , Dimopoulos, Meletios Α. , Lonial, Sagar , Terpos, Evangelos
HemaSphere | April 6, 2022 | Volume: 6 | Issue: No issue available | Pages: 18-18
